Darren Oplin
Director of Corporate Communications
Replay available
Axsome Therapeutics, Inc. (AXSM) Q2 2025 Earnings Call
Axsome Therapeutics, Inc. (NASDAQ: AXSM) Q2 2025 earnings conference call, held 2025-08-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Ariel Tabuto
Chief Executive Officer
Nick Pizzi
Chief Financial Officer
Ari Maizel
Chief Commercial Officer
Mark Jacobson
Chief Operating Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Axsome Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.999 Good morning, and welcome to the Axiom Therapeutics Second Quarter 2025 Financial Results 00:00:04.999 -- 00:00:09.185 Conference Call. Currently, all participants are in listen-only mode. 00:00:09.185 -- 00:00:12.249 Later, there will be a question-and-answer session, and instructions will be given at 00:00:12.249 -- 00:00:16.135 that time. Please note, this call is being recorded. 00:00:16.135 -- 00:00:20.642 I would now like to turn the call over to Darren Oplin, Director of Corporate Communications 00:00:20.642 -- 00:00:24.505 at Axiom Therapeutics. Please go ahead. 00:00:24.849 -- 00:00:29.150 Thank you, and good morning, everyone. Thank you all for joining us for our second quarter 00:00:29.150 -- 00:00:34.217 2025 earnings call. With me today are Dr. Ariel Tabuto, our 00:00:34.217 -- 00:00:39.604 Chief Executive Officer, Nick Pizzi, our Chief Financial Officer, and Ari Maizel, 00:00:39.604 -- 00:00:44.111 our Chief Commercial Officer, who will begin our call with prepared remarks. 00:00:44.111 -- 00:00:48.797 Mark Jacobson, our Chief Operating Officer, and Hunter Murdoch, our General Counsel, 00:00:48.797 -- 00:00:52.495 will join us for the Q&A portion of the call. 00:00:52.495 -- 00:00:56.821 This morning, we issued our earnings press release providing a business update and details 00:00:56.821 -- 00:01:00.046 of the company's financial results for the second quarter of 2025. 00:01:00.046 -- 00:01:01.808 I 00:01:01.808 -- 00:01:06.334 encourage everyone to visit the investor's page of our website to find our press release 00:01:06.334 -- 00:01:10.357 and the presentation related to today's call. 00:01:10.400 -- 00:01:14.966 Before we begin, please note that today's discussion includes certain forward-looking 00:01:14.966 -...